News

TEL AVIV, Israel and JACKSONVILLE, Fla., Aug. 22, 2023  -- RedDress, developers of the ActiGraft PRO system, a personalized and autologous wound care solution created from patients' own whole blood, today announced that its ActiGraft PRO product is now available through Vizient, the nation's largest provider-driven healthcare performance improvement company. RedDress secured an Innovative Technology contract with Vizient in October 2022 and G-Code reimbursement […]

HELSINKI and TEL AVIV, Israel and JACKSONVILLE, Fla., Aug. 8, 2023 —RedDress, developers of the ActiGraft system, a personalized and autologous wound care solution created from patients own whole blood, today announced that it has established a strategic partnership with OneMed, part of the Asker Healthcare Group, to commercialize and distribute the ActiGraft system throughout Finland. The multinational agreement is exclusive and follows […]

JACKSONVILLE, Fla., Jul 18, 2023 — RedDress, a personalized and autologous wound care solution created from patients own whole blood, today announced that its ActiGraft PRO product is now commercially available throughout the US and is eligible for reimbursement nationally from Medicare and Medicare Advantage via NCD 270.3 and G-0465 & G-0460 codes. ActiGraft PRO is […]

JACKSONVILLE, Fla., Nov 2, 2022 — RedDress, a privately held U.S. and Israel-based global medical device company, today announced their new wound care management system –ActiGraft+® system, will be commercially available in Puerto Rico. The product has been approved by MMM, Puerto Rico’s largest insurance provider, and the company has entered into a new distribution […]

JACKSONVILLE, Fla., Oct. 28, 2022 —RedDress, a privately held U.S. and Israel-based global medical device company, today announced the release of the new ActiGraft+® system – the next generation of their wound management system.  ActiGraft+, FDA-cleared, is an enhancement of the original technology designed to shorten the coagulation time and produce a higher-quality topically applied […]

JACKSONVILLE, Fla., Oct. 3, 2022— RedDress, a privately held U.S. and Israel-based global medical device company that features a suite of advanced wound care products, today announced it has received contract from Vizient, Inc., the nation’s leading health care performance improvement company serving more than half of the health care organizations across the United States. […]

JACKSONVILLE, Fla. — RedDress Medical, the American-Israeli medical company behind the advanced ActiGraft wound care systems, announced that their proprietary medical technology is now available in 40 countries across five continents, providing a viable alternative to more people around the world suffering from chronic and festering wounds that refuse to heal.   The 40 countries […]

TAMPA, Fla. – A wound care system helping elderly patients, diabetics and anyone struggling with healing deficiencies for stubborn wounds, will be showcased as a new and innovative solution at a medical conference in Tampa later this week as more doctors across a variety of specialties look to adopt the successful wound care treatment option […]

JACKSONVILLE, Fla. – A Florida-based Israeli medical company is shipping revolutionary blood-clotting wound care systems to Ukraine to help with serious injuries and severe trauma wounds, RedDress announced in a press release Wednesday. RedDress began shipments of 400 of their ActiGraft systems this week to multiple hospitals in Ukraine to help treat civilian casualties as […]

PONTE VEDRA BEACH, FLA., March 15, 2022 – RedDress, a privately held U.S. and Israel-based wound care company, announced today it has been awarded a group purchasing agreement with Premier Inc. This agreement allows Premier members, at their discretion, access to RedDress’ wound care product, ActiGraft® system.   ActiGraft is the first wound care product […]